Aarti Drugs

{
  "main_header": {
    "sid": 657348,
    "name": "Aarti Drugs",
    "stock_name": "Aarti Drugs",
    "full_name": "Aarti Drugs Ltd",
    "name_url": "stocks-analysis/aarti-drugs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "435.70",
    "chg": 3.9,
    "chgp": "0.9%",
    "dir": 1,
    "prev_price": "431.80",
    "mcapval": "3,976.63 Cr",
    "mcap": "Small Cap",
    "scripcode": 524348,
    "symbol": "AARTIDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE767A01016",
    "curr_date": "Sep 21, 02:30 PM",
    "curr_time": "14:49 PM",
    "last_traded_at": "Sep 21, 02:30 PM IST",
    "bse_nse_vol": "99.87 k",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-drugs-657348-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-hold-by-marketsmojo-4192568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AartiDrugsLtd_mojoScore_4192568.png",
        "date": "2026-09-14 10:10:05",
        "description": "Aarti Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Aarti Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-hold-by-marketsmojo-4181166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AartiDrugsLtd_mojoScore_4181166.png",
        "date": "2026-09-03 10:10:04",
        "description": "Aarti Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts to Bullish Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-to-bullish-amid-mixed-market-returns-4175353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_technicaldot_4175353.png",
        "date": "2026-08-31 08:01:46",
        "description": "Aarti Drugs Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance, supported by key indicators such as MACD, moving averages, and Bollinger Bands. Despite mixed returns relative to the Sensex over various timeframes, the pharmaceutical company’s recent price action and technical signals suggest a cautiously optimistic outlook for investors."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4172730",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_technicaldot_4172730.png",
        "date": "2026-08-28 08:02:16",
        "description": "Aarti Drugs Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of late August 2026. Despite a marginal day decline of 0.10%, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market."
      },
      {
        "title": "Aarti Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-hold-by-marketsmojo-4166062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_mojoScore_4166062.png",
        "date": "2026-08-23 10:10:03",
        "description": "Aarti Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Aarti Drugs Gains 0.17%: 4 Key Technical and Valuation Signals This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-gains-017-4-key-technical-and-valuation-signals-this-week-4155791",
        "imagepath": "",
        "date": "2026-08-15 16:04:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>10 Aug:</strong> Stock opens at Rs.421.35, up 1.20%</p>\n                    <p><strong>11 Aug:</strong> Strong intraday gain of 4.33%, closing at Rs.439.60</p>\n                    <p><strong>12 Aug:</strong> Formation of Golden Cross and Mojo Grade upgrade to Hold</p>\n                    <p><strong>13 Aug:</strong> Technical momentum shifts to bullish despite a 1.81% dip</p>\n                    <p><strong>14 Aug:</strong> Week closes at Rs.417.05, down 2.40% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.416.35</div></div>\n                   ..."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts to Bullish Amid Mixed Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-to-bullish-amid-mixed-returns-4151002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_technicaldot_4151002.png",
        "date": "2026-08-13 08:01:56",
        "description": "Aarti Drugs Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance across key indicators. Despite a recent dip in price and mixed long-term returns relative to the Sensex, the pharmaceutical company’s technical parameters suggest improving momentum and potential for recovery in the near term."
      },
      {
        "title": "Aarti Drugs Ltd Forms Golden Cross Amid Mixed Technical Signals and Modest Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4150533",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_goldencross_4150533.png",
        "date": "2026-08-12 18:00:44",
        "description": "The 50-day moving average for Aarti Drugs Ltd has crossed above the 200-day moving average, signalling a golden cross on 12 Aug 2026. Yet, the stock declined 1.81% on the day of the crossover, and the monthly technical indicators present a nuanced picture. This golden cross is technically valid but contextually complicated, warranting a closer look at the broader data."
      },
      {
        "title": "Aarti Drugs Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-4149510",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_mojoScore_4149510.png",
        "date": "2026-08-12 08:23:05",
        "description": "Aarti Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 11 Aug 2026, driven primarily by a shift in technical indicators and an attractive valuation profile despite flat recent financial performance. The company’s stock has shown signs of mild bullish momentum, prompting a reassessment of its outlook amid mixed fundamental signals."
      }
    ],
    "total": 715,
    "sid": "657348",
    "stock_news_url": "https://www.marketsmojo.com/news/aarti-drugs-657348"
  },
  "announcements": [
    {
      "details": "Disclosure under SEBI Takeover Regulations AARTIDRUGS : Seema Harshit Savla has submitted to the Exchange, vide letter dated November 21, 2019 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.",
      "source": "NSE",
      "caption": "Aarti Drugs Limited - Disclosure under SEBI Takeover Regulations",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Aarti Drugs Limitedany namely Aarti Speciality Chemicals Limited CIN No: U24230MH2019PLC333306 on November 20, 2019.",
      "source": "NSE",
      "caption": "Aarti Drugs Limited - Acquisition",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Disclosure under SEBI Takeover Regulations AARTIDRUGS : Seema Harshit Savla has submitted to the Exchange vide letter dated November 07, 2019 a copy of Disclosure as per Regulation 10(5) of SEBI (SAST) Regulation 2011",
      "source": "NSE",
      "caption": "Aarti Drugs Limited - Disclosure under SEBI Takeover Regulations",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has declared <strong>20%</strong> dividend, ex-date: 09 Feb 26",
          "dt": "2026-02-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 30 Sep 20",
          "dt": "2020-09-30",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Aarti Drugs Ltd is Rated Hold by MarketsMOJO

2026-09-14 10:10:05

Aarti Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Aarti Drugs Ltd is Rated Hold by MarketsMOJO

2026-09-03 10:10:04

Aarti Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts to Bullish Amid Mixed Market Returns

2026-08-31 08:01:46

Aarti Drugs Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance, supported by key indicators such as MACD, moving averages, and Bollinger Bands. Despite mixed returns relative to the Sensex over various timeframes, the pharmaceutical company’s recent price action and technical signals suggest a cautiously optimistic outlook for investors.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-28 08:02:16

Aarti Drugs Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of late August 2026. Despite a marginal day decline of 0.10%, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market.

Read full news article

Aarti Drugs Ltd is Rated Hold by MarketsMOJO

2026-08-23 10:10:03

Aarti Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Aarti Drugs Gains 0.17%: 4 Key Technical and Valuation Signals This Week

2026-08-15 16:04:19

Key Events This Week

10 Aug: Stock opens at Rs.421.35, up 1.20%

11 Aug: Strong intraday gain of 4.33%, closing at Rs.439.60

12 Aug: Formation of Golden Cross and Mojo Grade upgrade to Hold

13 Aug: Technical momentum shifts to bullish despite a 1.81% dip

14 Aug: Week closes at Rs.417.05, down 2.40% on the day

Week Open

Rs.416.35

...

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts to Bullish Amid Mixed Returns

2026-08-13 08:01:56

Aarti Drugs Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance across key indicators. Despite a recent dip in price and mixed long-term returns relative to the Sensex, the pharmaceutical company’s technical parameters suggest improving momentum and potential for recovery in the near term.

Read full news article

Aarti Drugs Ltd Forms Golden Cross Amid Mixed Technical Signals and Modest Momentum

2026-08-12 18:00:44

The 50-day moving average for Aarti Drugs Ltd has crossed above the 200-day moving average, signalling a golden cross on 12 Aug 2026. Yet, the stock declined 1.81% on the day of the crossover, and the monthly technical indicators present a nuanced picture. This golden cross is technically valid but contextually complicated, warranting a closer look at the broader data.

Read full news article

Aarti Drugs Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals

2026-08-12 08:23:05

Aarti Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 11 Aug 2026, driven primarily by a shift in technical indicators and an attractive valuation profile despite flat recent financial performance. The company’s stock has shown signs of mild bullish momentum, prompting a reassessment of its outlook amid mixed fundamental signals.

Read full news article

View All News